Disseminating a Waitlist Treatment for Anxiety With Velibra
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 11
- 试验地点
- 2
- 主要终点
- Feasibility (Percentage of participants who complete at least one module)
研究概览
简要总结
Cognitive Behavioral Therapy (CBT) is a gold standard treatment for a wide spectrum of anxiety-related concerns. However, long waitlist times can serve as a substantial barrier to those seeking treatment. Internet delivered psychotherapy, such as internet-based CBT (I-CBT) may present an affordable option for disseminating empirically supported treatments. Velibra, an web-based I-CBT intervention, has shown initial promise in treating anxiety disorders.
Velibra has been used to treat anxiety-related disorders in European samples with participants recruited from general practitioner's offices and diagnosed with a specific subset of anxiety disorders. While these effects are encouraging, additional research is needed toevaluate whether Velibra could be implemented in a community mental health clinic in the U.S. Specifically, if Velibra could be successfully implemented within the context of mental health clinic waitlists, it may be capable of providing evidence-based treatment to larger groups of people at a faster rate than mental health clinics can structurally support.
The purpose of this study is to assess the feasibility of implementing Velibra into an American community clinic waitlist. We plan to offer free access to the Velibra program to members of the Anxiety and Stress Clinic (ASC) waitlist at the University of Texas at Austin experiencing anxiety. We will evaluate interest in the program, user data from the program, and opinions of the program post-completion. We hypothesize ASC patients will find utility in Velibra's ability to offer them mental health resources faster than the traditional waitlist can provide.
详细描述
Waitlist Recruitment. Participants will be recruited directly from the Anxiety and Stress Clinic's waitlist. Consistent with our existing clinic screening procedures, individuals added to our waitlist meeting the following criteria will be invited to participate in this study:
- They have not experienced significant suicidal ideation in the past week.
- They do not meet for a bipolar I diagnosis without current utilization of stabilizing medications.
- They are not experiencing psychotic symptoms.
Upon meeting these criteria and being added to the clinic waitlist, patients will be asked if they would like to participate in our feasibility trial. Patients already on the waitlist at the time of study approval will also be contacted and offered participation. If interested in participating, patients will be asked to complete a digital informed consent via UT Qualtrics or Research Electronic Data Capture (REDCap), secure, online assessment tools designed to collect self-report questionnaire data for research studies.
Baseline Survey. Following informed consent, participants will complete a baseline survey via UT Qualtrics or REDCap. This survey will include measures of anxiety and other internalizing symptoms (Patient Health Questionnaire, PHQ-9; Generalized Anxiety Disorder 7-item Scale, GAD-7; Overall Anxiety Severity and Impairment Scale, OASIS). Other questions will evaluate participants' current medication/treatment status (Treatment/Medication Status questions). More details about these questionnaires included below. Following completion of the baseline survey, participants will receive a voucher for free access to Velibra.
Velibra Program. All treatment will be provided via the Velibra website: https://velibra.broca.io/en/registration/voucher. While the Velibra treatment is only six weeks long, participants will have free access to the program for 24 weeks. They can access this website as often as they would like. The Velibra program is self-guided, so participants determine how often they access the material (the program encourages participants to complete one of six sessions per week for six weeks).
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Currently on the Anxiety and Stress Clinic waitlist
- •At least 18 years old
- •Fluent in English
- •Have access to a computer or web device
排除标准
- •Active suicidal ideation with intent to harm oneself in the past week (e.g., endorses "Yes" toC-SSRS item 4 or higher).
- •A formal diagnosis of Bipolar I disorder without current utilization of stabilizing medications.
- •Present or past psychosis
结局指标
主要结局
Feasibility (Percentage of participants who complete at least one module)
时间窗: [assessed at 6-week follow-up]
Percentage of participants who complete at least one module of Velibra (out of the total number of participants offered access to the program).
次要结局
- System Usability Scale (Brooke, 1996)([assessed at 6-week follow-up])
- Client Satisfaction Questionnaire (Larsen, Attkisson, Hargreaves, & Nguyen, 1979)([assessed at 6-week follow-up])
- Treatment-Seeking Behavior([assessed at 6-week follow-up])
- Overall Anxiety Severity and Impairment Scale (Norman, Hammi Cissell, Means-Christensen, & Stein, 2006)([assessed at baseline and 6-week follow-up])
- Generalized Anxiety Disorder Scale-7 (Spitzer, Kroenke, Williams, & Lowe, 2006)([assessed at baseline and 6-week follow-up])
- Patient Health Questionnaire (Kroenke, Spitzer, & Williams, 2001)([assessed at baseline and 6-week follow-up])
研究者
Jasper A. Smits
Professor
University of Texas at Austin